Givaudan Net Profit Rises Despite Drop in Sales
By Adria Calatayud
Givaudan reported a rise in net profit for last year, thanks to cost controls that allowed it to increase profitability and offset a drop in sales.
Net profit for 2023 was 893 million Swiss francs ($1.04 billion) compared with CHF856 million a year before, the Swiss supplier of chemicals to the food and cosmetics industries said Thursday.
Sales fell to CHF6.915 billion from CHF7.12 billion, dragged by a decline in the company's taste-and-wellbeing segment, it said. For the fourth quarter alone, sales fell 0.5% to CHF1.65 billion.
Full-year earnings before interest, taxes, depreciation and amortization inched lower to CHF1.47 billion from CHF1.48 billion, but Givaudan's Ebitda margin improved to 21.3% from 20.7%, which it attributed to cost management across the business and a performance-improvement program.
Analysts expected Givaudan's 2023 net profit, Ebitda and sales at CHF842 million, CHF1.47 billion and CHF6.92 billion, respectively, according to consensus estimates provided by the company.
The company said it is on track for its 2025 targets, which include average annual organic sales growth of 4% to 5% over a five-year period.
It intends to propose a dividend of CHF68 a share for 2023, up 1.5% on year.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
January 25, 2024 01:23 ET (06:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth